Key result
Hemodialysis patients have a 25 to 130 times higher incidence of sudden cardiac death compared to non-chronic kidney disease patients, necessitating hemodialysis-specific arrhythmia management.
Management of arrhythmias in hemodialysis patients requires special consideration, as standard therapies like ICDs and warfarin may have reduced efficacy or increased risks compared to the general population.
May warrant tailored arrhythmia strategies in hemodialysis; leaves open optimal interventions pending prospective trials.
No takes yet. Share an insight, caveat, or question.
Hiroki Hase (2012) conducted a review in Sudden cardiac death and dysrhythmia in hemodialysis patients. Arrhythmia management (ICD, beta-blockers, warfarin, rate control) was evaluated. Hemodialysis patients have a 25 to 130 times higher incidence of sudden cardiac death compared to non-chronic kidney disease patients, necessitating hemodialysis-specific arrhythmia management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: